查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446443

經皮給藥系統市場規模、佔有率、趨勢分析報告：按技術、按應用、按地區、細分市場預測，2024-2030

Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Iontophoresis, Mechanical Arrays), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

經皮給藥系統市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球經皮給藥系統市場規模預計將達到1,450.4億美元，複合年成長率為11.9%。

經皮吸收貼片的接受度不斷提高，特別是對於糖尿病等需要持續每日注射胰島素劑量的疾病，預計將推動經皮給藥系統領域的市場成長。

此外，糖尿病患者需要定期注射胰島素，傳統上透過注射給藥，這可能會引起不適並增加疾病傳播的風險。因此，經皮遞送系統似乎是遞送胰島素的更有吸引力的選擇。促進市場成長的另一個重要因素是對無痛給藥的需求不斷成長。持續注射胰島素會導致不適和慢性疾病。經皮吸收貼片可以解決這些問題，因為它們提供了一種更舒適、更有效的胰島素輸送方法。

此外，隨著糖尿病、心臟病和疼痛相關問題等慢性疾病在世界各地變得越來越普遍，對有效且患者友善的藥物傳遞方法的需求日益成長。例如，根據美國心臟協會2022年全球疾病負擔報告，死亡率為239.8，盛行率為每10萬人7354.1。經皮給藥系統具有多種優點，包括非侵入性、受控藥物釋放、提高患者依從性和最小化副作用。對這種方便用戶使用的藥物輸送系統的需求不斷成長，特別是對長期藥物的持續管理，正在推動經皮藥物輸送市場的成長。

經皮給藥系統市場報告重點：

  • 2023年，離子電滲透療法領域佔最大市場佔有率。這可能是由於使用電流通過皮膚非侵入性地輸送藥物的有效性。
  • 2023年，由於慢性疾病和創傷（包括關節炎、骨關節炎和整形外科退化性疾病等肌肉骨骼疾病）的盛行率不斷增加，疼痛管​​理領域引領了應用領域。這些疾病的日益普及正在促進並推動該領域的發展。
  • 在到 2023 年的預測期內，荷爾蒙應用領域預計將以指數複合年成長率成長。這是由於對方便的荷爾蒙療法的需求不斷增加。經皮給藥的功效和簡單性使其成為荷爾蒙給藥的有吸引力的解決方案。
  • 由於先進的醫療基礎設施以及慢性疼痛、中樞神經系統疾病和心血管疾病等目標疾病的高盛行率，北美地區在 2023 年佔據最大的市場佔有率。
  • 市場參與者已採取多項策略舉措來擴大產品覆蓋範圍並提高不同地區的可用性。

目錄

第1章經皮給藥系統市場：調查方法與範圍

第2章經皮給藥系統市場：執行摘要

  • 市場展望
  • 分部展望
  • 競爭考察

第3章經皮系統市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 經皮給藥系統市場分析工具

第4章經皮給藥系統市場：技術評估與趨勢分析

  • 定義和範圍
  • 2023年及2030年技術市場佔有率
  • 細分儀表板
  • 按技術展望分類的全球經皮系統市場
  • 2018年至2030年市場應用與預測及趨勢分析

第5章經皮給藥系統市場：應用估計與趨勢分析

  • 定義和範圍
  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 全球經皮給藥系統市場應用前景展望
  • 2018年至2030年市場應用與預測及趨勢分析

第6章經皮給藥系統市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Novartis AG
    • Johnson &Johnson
    • Mylan Pharmaceuticals, Inc.
    • Boehringer Ingelheim GmbH
    • AbbVie
    • Grunenthal
    • Skyepharma
    • 3M Company
    • Noven Pharmaceuticals, Inc.
    • 4P Therapeutics, LLC
    • Hisamitsu Pharmaceutical co. Inc
Product Code: GVR-1-68038-062-0

Transdermal Drug Delivery Systems Market Growth & Trends:

The global transdermal drug delivery systems market size is anticipated to reach to reach USD 145.04 billion by 2030, expanding at a CAGR of 11.9%, based on a new report by Grand View Research, Inc. The growing acceptance of transdermal patches, particularly for conditions like diabetes that necessitate consistent and daily insulin dosage, is projected to drive market growth in the transdermal drug delivery systems sector.

In addition, diabetes patients require regular insulin administration, traditionally done through injections, which can cause discomfort and increase the risk of disease transmission. This makes transdermal drug delivery system will be a more appealing alternative for delivering insulin.Another significant factor contributing to the growth of the market is the rising demand for painless drug delivery. The constant use of injections for insulin administration can lead to discomfort and even chronic diseases. Transdermal patches offer a more comfortable and efficient way of delivering insulin, thus addressing these issues.

Moreover, chronic diseases like diabetes, heart conditions, and pain-related issues become more common globally, there is a greater need for drug delivery methods that are both effective and easy for patients to use. For example, according to the American Heart Association's 2022 report on the Global Burden of Disease, the death rate per 100,000 people was 239.8, while the prevalence rate was 7354.1 per 100,000. Transdermal drug delivery systems come with multiple benefits such as being non-invasive, providing controlled drug release, enhancing patient adherence, and minimizing side effects. This increasing demand for user-friendly drug delivery systems, particularly for the ongoing management of long-term medications, is driving the transdermal drug delivery market growth.

Transdermal Drug Delivery Systems Market Report Highlights:

  • In 2023, the iontophoresis segment accounted for the largest market share. This can be attributed due to its effectiveness in delivering medications non-invasively through the skin using electrical currents
  • In 2023, the pain management segment led the application segment due to the increasing prevalence of chronic diseases and trauma, including musculoskeletal disorders such as arthritis, osteoarthritis, and orthopedic degenerative disorders. The growing prevalence of these conditions is contributing, driving the segment growth
  • The hormone segment is expected to grow at an exponential CAGR during the forecast period in the application segment in 2023. This is due to rising demand for convenient hormone therapies. Transdermal delivery's effectiveness and user-friendliness make it an attractive solution for administering hormones
  • The North American region held the largest market share in 2023 due to advanced healthcare infrastructure and high prevalence of targeted diseases like chronic pain, central nervous system disorders, and cardiovascular diseases in the region
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Transdermal Drug Delivery Systems Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Transdermal Drug Delivery Systems Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transdermal Drug Delivery Systems Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing adoption of transdermal patches
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. High demand for pain free drug delivery
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of transdermal technology
      • 3.2.2.2. Limited number of approved medications
  • 3.3. Transdermal Drug Delivery System Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Transdermal Drug Delivery Systems Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Electroporation
    • 4.1.2. Radio Frequency
    • 4.1.3. Iontophoresis
    • 4.1.4. Microporation
    • 4.1.5. Thermal
    • 4.1.6. Mechanical arrays
    • 4.1.7. Ultrasound
    • 4.1.8. Others
  • 4.2. Technology Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Transdermal Drug Delivery System Market by Technology Outlook
  • 4.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Electroporation
      • 4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
    • 4.5.2. Radio Frequency
      • 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.3. Iontophoresis
      • 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.4. Microporation
      • 4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.5. Thermal
      • 4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.6. Mechanical Arrays
      • 4.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.7. Ultrasound
      • 4.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.8. Others
      • 4.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Transdermal Drug Delivery System Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. CNS
    • 5.1.2. Pain Management
    • 5.1.3. Cardiovascular
    • 5.1.4. Hormone
    • 5.1.5. Immunological
    • 5.1.6. Metabolic
    • 5.1.7. Gastrointestinal
    • 5.1.8. Infection
    • 5.1.9. Cancer
    • 5.1.10. Others
  • 5.2. Application Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Transdermal Drug Delivery System Market by Application Outlook
  • 5.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. CNS
      • 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.2. Pain Management
      • 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.3. Cardiovascular
      • 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.4. Hormone
      • 5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.5. Immunological
      • 5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.6. Metabolic
      • 5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.7. Gastrointestinal
      • 5.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.8. Infection
      • 5.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.9. Cancer
      • 5.5.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.5.10. Others
      • 5.5.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 6. Transdermal Drug Delivery System Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Novartis AG
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Johnson & Johnson
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Mylan Pharmaceuticals, Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Boehringer Ingelheim GmbH
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. AbbVie
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Grunenthal
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Skyepharma
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. 3M Company
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Noven Pharmaceuticals, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. 4P Therapeutics, LLC
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Hisamitsu Pharmaceutical co. Inc
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of Abbreviation
  • Table 3. North America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 5. North America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 6. U.S. transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 7. U.S. transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 8. Canada transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 9. Canada transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 10. Europe transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
  • Table 11. Europe transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 12. Europe transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 13. Germany transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 14. Germany transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 15. UK transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 16. UK transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 17. France transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 18. France transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 19. Italy transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 20. Italy transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 21. Spain transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 22. Spain transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 23. Denmark transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 24. Denmark transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 25. Sweden transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 26. Sweden transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 27. Norway transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Norway transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 29. APAC transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
  • Table 30. APAC transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 31. APAC transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 32. Japan transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 33. Japan transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 34. India transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 35. India transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 36. China transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 37. China transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 38. South Korea transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 39. South Korea transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 40. Thailand transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 41. Thailand transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 42. Australia transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Australia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 44. Latin America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
  • Table 45. Latin America transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 46. Latin America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 47. Brazil transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 48. Brazil transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 49. Mexico transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Mexico transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 51. Argentina transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 52. Argentina transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 53. Middle East and Africa transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
  • Table 54. Middle East and Africa transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 55. Middle East and Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 56. South Africa transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 57. South Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 58. Saudi Arabia transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 59. Saudi Arabia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 60. UAE transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 61. UAE transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
  • Table 62. Kuwait transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
  • Table 63. Kuwait transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Transdermal drug delivery system segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement process
  • Fig 4. Primary research pattern
  • Fig 5. Transdermal drug delivery system snapshot, 2023 (USD Million)
  • Fig 6. Segment snapshot, USD Million
  • Fig 7. Competitive landscape snapshot
  • Fig 8. Penetration & growth prospect mapping, by product
  • Fig 9. Market driver analysis (Current & future impact)
  • Fig 10. Market restraint analysis (Current & future impact)
  • Fig 11. Transdermal drug delivery system market, technology outlook key takeaways (USD Million)
  • Fig 12. Transdermal drug delivery system: technology movement analysis (USD Million), 2023 & 2030
  • Fig 13. Electroporation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Radio frequency market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Iontophoresis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 16. Microporation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 17. Thermal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 18. Mechanical arrays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 19. Ultrasound market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Transdermal drug delivery systems market: application movement analysis (USD Million), 2023 & 2030
  • Fig 22. CNS market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Pain Management market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. Cardiovascular market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Hormone market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. Immunological market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Metabolic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Gastrointestinal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. Infection market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Transdermal drug delivery system market: Regional key takeaways (USD Million)
  • Fig 33. Transdermal drug delivery system market: Regional outlook, 2023 & 2030, USD Million
  • Fig 34. North America transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. U.S. transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. Canada transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Europe transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. UK transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Germany transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. France transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. Spain transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Italy transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. Sweden transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Norway transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. Denmark transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. Asia Pacific transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 47. China transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 48. Japan transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 49. India transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 50. South Korea transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 51. Australia transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 52. Thailand transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 53. Latin America transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 54. Brazil transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 55. Mexico transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 56. Argentina transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 57. Middle East and Africa transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 58. South Africa transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 59. Saudi Arabia transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 60. UAE transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 61. Kuwait transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 62. List of key emerging company's/technology disruptors/innovators